What is it about?
PTSD treatment research needs to reevaluate the use of non-inferiority (NI) trials to establish efficacy and for comparative effectiveness. Their rise in use without effective attention to design differences is reducing the quality of the evidence base to guide effective PTSD treatment. Given limitations, NI studies may be appropriate to compare validated treatment delivered in different modalities or with different subgroups. They are not a substitution for placebo controlled or comparative effectiveness trials.
Featured Image
Read the Original
This page is a summary of: Problems With Noninferiority Designs in PTSD Treatment Research: Losing Signal to Noise, American Journal of Psychiatry, May 2025, American Psychiatric Association,
DOI: 10.1176/appi.ajp.20240567.
You can read the full text:
Contributors
Be the first to contribute to this page







